Body-Focused Mindfulness as an Add-on Intervention in Inpatient Alcohol Use Disorder Treatment (MBI-AUD-PL)
MBI-AUD-PL
Effects of a Body-Focused Mindfulness Intervention Added to Standard Inpatient Alcohol Use Disorder Treatment on Emotion Regulation, Interoceptive Awareness, and Alcohol Craving: A Randomized Controlled Trial
1 other identifier
interventional
240
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a body-focused mindfulness program can help people with alcohol use disorder (AUD) feel more connected to their bodies and manage their emotions better. The main questions it aims to answer are: Does the mindfulness program reduce feelings of disconnection from the body (bodily dissociation)? Does it improve awareness of body signals (interoceptive awareness)? Does it lower alcohol craving and reduce the chance of returning to drinking after leaving the hospital? Researchers will compare participants who receive the mindfulness program to participants who receive standard psychoeducation sessions, within the same overall inpatient AUD treatment program. Participants will:
- Take part in 6 weekly group sessions (90 minutes each) of body-focused mindfulness, which includes breathing exercises, body scan, gentle movement, and group discussion.
- Receive audio recordings of guided mindfulness exercises to practice independently between sessions.
- Complete questionnaires about their emotions, body awareness, and alcohol craving before and after the program.
- Be followed up at 4 weeks, 6 months, and 12 months after leaving the hospital to track their drinking.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2029
July 16, 2026
July 1, 2026
2.4 years
June 15, 2026
July 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2) - total score
The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2) is a 37-item self-report questionnaire assessing eight dimensions of interoceptive awareness including noticing, attention regulation, emotional awareness, self-regulation, body listening, and trusting bodily sensations (Mehling et al., 2018). Total score ranges from 0 to 185, with higher scores indicating greater interoceptive awareness (better outcome).
Baseline and 6 weeks
Secondary Outcomes (11)
Scale of Body Connection - Bodily Dissociation subscale (SBC-BD)
Baseline and 6 weeks
Difficulties in Emotion Regulation Scale (DERS) - total score
Baseline and 6 weeks
Toronto Alexithymia Scale (TAS-20) - total score
Baseline and 6 weeks
Dissociative Experiences Scale (DES) - total score
Baseline and 6 weeks
Penn Alcohol Craving Scale (PACS)
Baseline and 6 weeks
- +6 more secondary outcomes
Other Outcomes (2)
Body Maps - Bodily Sensation Phenomenology (paper-based measure)
Baseline and 6 weeks
Post-Session Single-Item Measures (three NRS items)
After each session, up to 6 weeks
Study Arms (2)
Body-Focused Mindfulness
EXPERIMENTALParticipants receive standard inpatient AUD treatment plus 6 weekly 90-minute body-focused mindfulness group sessions (breath awareness, body scan, mindful movement, and structured inquiry). Sessions are delivered in an open circular group format without direct reference to alcohol use. Participants receive audio recordings of guided mindfulness exercises and are encouraged to practice independently (5-10 minutes daily) between sessions.
Psychoeducation (Active Comparator)
ACTIVE COMPARATORParticipants receive standard inpatient AUD treatment plus 6 weekly 90-minute psychoeducation group sessions covering standard topics related to alcohol use disorder, recovery, and coping strategies. All other components of the treatment program are identical to the experimental group.
Interventions
Six weekly 90-minute group sessions incorporating breath-focused meditation, body scan (lying and seated positions), mindful movement and stretching, and structured inquiry. Delivered in an open circular group format by therapists trained in mindfulness-based approaches. No direct reference to alcohol use. Participants receive audio recordings of guided mindfulness exercises and are encouraged to practice independently (5-10 minutes daily) between sessions.
Six weekly 90-minute group psychoeducation sessions added to standard inpatient AUD treatment. Sessions cover standard topics related to alcohol use disorder, recovery, and coping strategies. Delivered by the same therapists as the experimental group. All other components of the inpatient treatment program are identical between groups.
Eligibility Criteria
You may qualify if:
- Diagnosis of Alcohol Use Disorder (DSM-5)
- Currently admitted to the inpatient AUD treatment program at the study ward
- Age 18 years or older
- Written informed consent provided
You may not qualify if:
- Refusal to participate or withdrawal of consent
- Severe somatic condition precluding participation in group activities
- Current acute psychotic symptoms
- Severe affective symptoms requiring intensive intervention
- High current suicide risk
- Epileptic seizure within 2 weeks prior to randomization
- Intellectual disability or significant cognitive impairment preventing understanding of or adherence to the study protocol
- Severe personality disorder with current self-harm or other-harm behaviors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Warsawlead
- University of Warsawcollaborator
Study Sites (1)
Ward XVIII for Alcohol Use Disorder Treatment, Nowowiejski Hospital, Warsaw
Warsaw, Mazovian, 01-045, Poland
Related Publications (4)
Cheng SC, Thompson EA, Price CJ. The Scale of Body Connection: A Multisample Study to Examine Sensitivity to Change Among Mind-Body and Bodywork Interventions. J Integr Complement Med. 2022 Jul;28(7):600-606. doi: 10.1089/jicm.2021.0397. Epub 2022 Apr 22.
PMID: 35452263BACKGROUNDPrice CJ, Thompson EA. Measuring dimensions of body connection: body awareness and bodily dissociation. J Altern Complement Med. 2007 Nov;13(9):945-53. doi: 10.1089/acm.2007.0537.
PMID: 18047441BACKGROUNDMehling WE, Acree M, Stewart A, Silas J, Jones A. The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). PLoS One. 2018 Dec 4;13(12):e0208034. doi: 10.1371/journal.pone.0208034. eCollection 2018.
PMID: 30513087BACKGROUNDTreves IN, Chen YY, Wilson CL, Verdonk C, Qina'au J, Pustejovsky JE, Goldberg SB, Mehling W, Schuman-Olivier Z, Khalsa SS. Minding the Body: A Meta-analysis of the Effects of Mindfulness Meditation Training on Self-reported Interoception. Res Sq [Preprint]. 2025 Jun 4:rs.3.rs-6792067. doi: 10.21203/rs.3.rs-6792067/v1.
PMID: 40502790BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrzej Jakubczyk, MD, PhD
Medical University of Warsaw
- STUDY CHAIR
Marcin Wojnar, MD, PhD
Medical University of Warsaw
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Psychiatry, Medical University of Warsaw
Study Record Dates
First Submitted
June 15, 2026
First Posted
July 16, 2026
Study Start
July 1, 2026
Primary Completion (Estimated)
December 1, 2028
Study Completion (Estimated)
December 1, 2029
Last Updated
July 16, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared publicly due to ethical considerations related to sensitive clinical data, including alcohol use disorder diagnosis, psychiatric history, and trauma history. Aggregate data and study materials will be available upon reasonable request to the corresponding author following publication.